Klotho is an endogenous antagonist of Wnt/β-catenin signaling pathway [121] whose activation has been observed in a variety of CKD experimental models, predominantly in damaged renal tubular epithelial cells [121,122,123,124]. Here, KL is linked to chronic kidney disease.